Figure 6.

Observed vs. individual predicted drug (left), luteinizing hormone (LH) (middle) and testosterone (right) concentrations plotted on a double-logarithmic scale after treatment with triptorelin (top) and degarelix (bottom). The dashed lines represent the lower limit of quantification (LLOQ) of 0.01 ng ml⁻¹ (triptorelin), 0.5 ng ml⁻¹ (degarelix), 0.1 IU l⁻¹ (LH) and 0.05 ng ml⁻¹ (testosterone). The solid lines are the lines of identity